Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2011 2
2012 1
2013 1
2014 1
2015 2
2018 2
2019 1
2020 2
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Antileishmanial pharmacomodulation in 8-nitroquinolin-2(1H)-one series.
Kieffer C, Cohen A, Verhaeghe P, Paloque L, Hutter S, Castera-Ducros C, Laget M, Rault S, Valentin A, Rathelot P, Azas N, Vanelle P. Kieffer C, et al. Among authors: castera ducros c. Bioorg Med Chem. 2015 May 15;23(10):2377-86. doi: 10.1016/j.bmc.2015.03.064. Epub 2015 Mar 31. Bioorg Med Chem. 2015. PMID: 25846065
Pre-formulation and Stability Study of 20-mcg Clonidine Hydrochloride Pediatric Capsules.
Wasilewski M, Curti C, Panuccio C, Bouguergour C, Primas N, Lamy E, Castera-Ducros C, Jean C, Bertault-Peres P, Vanelle P. Wasilewski M, et al. Among authors: castera ducros c. J Pediatr Pharmacol Ther. 2022;27(7):625-631. doi: 10.5863/1551-6776-27.7.625. Epub 2022 Sep 26. J Pediatr Pharmacol Ther. 2022. PMID: 36186250 Free PMC article.
Improving Aqueous Solubility and In Vitro Pharmacokinetic Properties of the 3-Nitroimidazo[1,2-a]pyridine Antileishmanial Pharmacophore.
Paoli-Lombardo R, Primas N, Bourgeade-Delmas S, Hutter S, Sournia-Saquet A, Boudot C, Brenot E, Castera-Ducros C, Corvaisier S, Since M, Malzert-Fréon A, Courtioux B, Valentin A, Verhaeghe P, Azas N, Rathelot P, Vanelle P. Paoli-Lombardo R, et al. Among authors: castera ducros c. Pharmaceuticals (Basel). 2022 Aug 13;15(8):998. doi: 10.3390/ph15080998. Pharmaceuticals (Basel). 2022. PMID: 36015146 Free PMC article.
8-Aryl-6-chloro-3-nitro-2-(phenylsulfonylmethyl)imidazo[1,2-a]pyridines as potent antitrypanosomatid molecules bioactivated by type 1 nitroreductases.
Fersing C, Boudot C, Pedron J, Hutter S, Primas N, Castera-Ducros C, Bourgeade-Delmas S, Sournia-Saquet A, Moreau A, Cohen A, Stigliani JL, Pratviel G, Crozet MD, Wyllie S, Fairlamb A, Valentin A, Rathelot P, Azas N, Courtioux B, Verhaeghe P, Vanelle P. Fersing C, et al. Among authors: castera ducros c. Eur J Med Chem. 2018 Sep 5;157:115-126. doi: 10.1016/j.ejmech.2018.07.064. Epub 2018 Aug 1. Eur J Med Chem. 2018. PMID: 30092366 Free PMC article.
Nongenotoxic 3-Nitroimidazo[1,2-a]pyridines Are NTR1 Substrates That Display Potent in Vitro Antileishmanial Activity.
Fersing C, Basmaciyan L, Boudot C, Pedron J, Hutter S, Cohen A, Castera-Ducros C, Primas N, Laget M, Casanova M, Bourgeade-Delmas S, Piednoel M, Sournia-Saquet A, Belle Mbou V, Courtioux B, Boutet-Robinet É, Since M, Milne R, Wyllie S, Fairlamb AH, Valentin A, Rathelot P, Verhaeghe P, Vanelle P, Azas N. Fersing C, et al. Among authors: castera ducros c. ACS Med Chem Lett. 2018 Dec 19;10(1):34-39. doi: 10.1021/acsmedchemlett.8b00347. eCollection 2019 Jan 10. ACS Med Chem Lett. 2018. PMID: 30655943 Free PMC article.
8-Alkynyl-3-nitroimidazopyridines display potent antitrypanosomal activity against both T. b. brucei and cruzi.
Fersing C, Boudot C, Castera-Ducros C, Pinault E, Hutter S, Paoli-Lombardo R, Primas N, Pedron J, Seguy L, Bourgeade-Delmas S, Sournia-Saquet A, Stigliani JL, Brossas JY, Paris L, Valentin A, Wyllie S, Fairlamb AH, Boutet-Robinet É, Corvaisier S, Since M, Malzert-Fréon A, Destere A, Mazier D, Rathelot P, Courtioux B, Azas N, Verhaeghe P, Vanelle P. Fersing C, et al. Among authors: castera ducros c. Eur J Med Chem. 2020 Sep 15;202:112558. doi: 10.1016/j.ejmech.2020.112558. Epub 2020 Jul 8. Eur J Med Chem. 2020. PMID: 32652409
Discovery of a new antileishmanial hit in 8-nitroquinoline series.
Paloque L, Verhaeghe P, Casanova M, Castera-Ducros C, Dumètre A, Mbatchi L, Hutter S, Kraiem-M'rabet M, Laget M, Remusat V, Rault S, Rathelot P, Azas N, Vanelle P. Paloque L, et al. Among authors: castera ducros c. Eur J Med Chem. 2012 Aug;54:75-86. doi: 10.1016/j.ejmech.2012.04.029. Epub 2012 May 2. Eur J Med Chem. 2012. PMID: 22608675
Looking for new antileishmanial derivatives in 8-nitroquinolin-2(1H)-one series.
Kieffer C, Cohen A, Verhaeghe P, Hutter S, Castera-Ducros C, Laget M, Remusat V, M'Rabet MK, Rault S, Rathelot P, Azas N, Vanelle P. Kieffer C, et al. Among authors: castera ducros c. Eur J Med Chem. 2015 Mar 6;92:282-94. doi: 10.1016/j.ejmech.2014.12.056. Epub 2014 Dec 31. Eur J Med Chem. 2015. PMID: 25559208
4-Thiophenoxy-2-trichloromethyquinazolines display in vitro selective antiplasmodial activity against the human malaria parasite Plasmodium falciparum.
Verhaeghe P, Dumètre A, Castera-Ducros C, Hutter S, Laget M, Fersing C, Prieri M, Yzombard J, Sifredi F, Rault S, Rathelot P, Vanelle P, Azas N. Verhaeghe P, et al. Among authors: castera ducros c. Bioorg Med Chem Lett. 2011 Oct 1;21(19):6003-6. doi: 10.1016/j.bmcl.2011.06.113. Epub 2011 Jul 2. Bioorg Med Chem Lett. 2011. PMID: 21852132
15 results